"A super talent!" - Fabrizio Romano rates Chelsea's transfer window performance
How did Chelsea get on with their summer business? A look at the ins and outs, plus insight from Fabrizio Romano...
Chelsea were one of the busiest clubs of the transfer window again this summer, but is there a method to the madness? Read on for our review of Chelsea’s business, featuring analysis from our columnist Fabrizio Romano…
Players in
Joao Felix - Back at Chelsea for a second spell, this one will have come as a bit of a surprise to many fans after the Blues seemed to be going after a different style of attacking player, only to then pivot quite quickly to Joao Felix when it became necessary as part of their deal to sell Conor Gallagher to Atletico Madrid. Still, Felix is an elite talent on his day, and has started brightly under Enzo Maresca.
Pedro Neto - A stand-out performer for Wolves in recent years, Pedro Neto had also been linked with the likes of Arsenal and Manchester City before Chelsea moved quickly for him towards the end of pre-season. The Portuguese winger has the pace, skill and all-round quality to be a real hit at Stamford Bridge, whilst also being young enough not to deviate too much away from the club’s policy of investing in the future.
Kiernan Dewsbury-Hall - A top performer under Maresca when they were together at Leicester City last season, it remains to be seen how much of a key role Kiernan Dewsbury-Hall will play at Chelsea, but he’s an interesting addition to give them something a little different in midfield.
Estevao Willian - One of the world’s top young talents, Estevao Willian is still at Palmeiras for now, but has an agreement in place to join Chelsea in the future in what should be a superb piece of business for the club’s long-term success.
Tosin Adarabioyo - Signed on a free transfer after his contract at Fulham ended, Tosin Adarabioyo isn’t exactly the most exciting signing in the world, but he’s a proven Premier League player who should add decent depth to this Blues side.
Keep reading with a 7-day free trial
Subscribe to the Daily Briefing to keep reading this post and get 7 days of free access to the full post archives.